Patients & Volunteers Information for those interested or currently participating in a clinical trial
	Research Sponsors Why you should choose Aurora for your clinical trials
	Investigators & Coordinators Learn more about our services
	Research Matters Quarterly newsletter about research at Aurora
	Links Learn more about clinical research
	Contact us Contact the Clinical Research department
	Return home Return to the Clinical Research home page

Select from the search options to widen or narrow the search results.

Atrial fibrillation study

The purpose of this research study is to study heart rhythm after surgery and to show the Cardioblate system is safe and effective to treat AF. The (CURE-AF) and (CURE-AF Persistent) Studies Use Radio Frequency Energy for surgically treating Atrial Fibrillation during the MAZE procedure.

To participate in the CURE-AF and CURE-AF Persistent study you must:

• Must have a documented history of persistent AF or permanent AF (cardioversion failure)
• Must need open heart surgery other than the MAZE procedure Greater than or equal to 18 years of age
• Must be able to take the anticoagulant warfarin (Coumadin)

For more information

To find out if you or someone you know may be eligible to participate, contact Jennifer Cooper, RN, at 414-385-2504.

Dr. David Kress, Principal Investigator

Clinical trial location(s)

[ previous page ]

Copyright Aurora Health Care, a not-for-profit health care provider serving Wisconsin.
3000 W. Montana St., Milwaukee, WI 53215, (414) 647-3000
Disclaimer | Privacy notice | Contact us
.